The PE Ratio as of November 2024 (TTM) for Rigel Pharmaceuticals, Inc. (RIGL) is 96.44

According to Rigel Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 96.44. This represents a change of 686.87% compared to the average of 12.26 of the last 4 quarters.

Rigel Pharmaceuticals, Inc. (RIGL) Historical PE Ratio (quarterly & annually)

How has RIGL PE Ratio performed in the past?

The mean historical PE Ratio of Rigel Pharmaceuticals, Inc. over the last ten years is -8.65. The current 96.44 PE Ratio has changed -111652.72% with respect to the historical average. Over the past ten years (40 quarters), RIGL's PE Ratio was at its highest in in the December 2022 quarter at 89.66. The PE Ratio was at its lowest in in the June 2024 quarter at -35.82.

Rigel Pharmaceuticals, Inc. (RIGL) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Rigel Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Rigel Pharmaceuticals, Inc. (RIGL) Average PE Ratio

How has RIGL PE Ratio performed in the past?

The current PE Ratio of Rigel Pharmaceuticals, Inc. (RIGL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Rigel Pharmaceuticals, Inc. (RIGL) PE Ratio vs. Peers

How is RIGL’s PE Ratio compared to its peers?

Rigel Pharmaceuticals, Inc.’s PE Ratio is greater than Fortress Biotech, Inc. (-0.62), greater than Reviva Pharmaceuticals Holdings, Inc. (-1.19), greater than CTI BioPharma Corp. (-11.46), greater than Ocuphire Pharma, Inc. (-2.14), greater than Nabriva Therapeutics plc (-0.07), greater than Eiger BioPharmaceuticals, Inc. (-0.05), greater than Pieris Pharmaceuticals, Inc. (-1.39), greater than Cidara Therapeutics, Inc. (-1.10), greater than X4 Pharmaceuticals, Inc. (-4.05), greater than Mereo BioPharma Group plc (-13.56), greater than Inozyme Pharma, Inc. (-1.84), greater than Terns Pharmaceuticals, Inc. (-5.12), greater than Leap Therapeutics, Inc. (-1.63), greater than Zura Bio Limited (-5.60), greater than Enveric Biosciences, Inc. (-0.29), greater than eFFECTOR Therapeutics, Inc. (-0.00), greater than Immix Biopharma, Inc. (-2.41), greater than Elevation Oncology, Inc. (-0.85), greater than Day One Biopharmaceuticals, Inc. (-15.73), greater than Acumen Pharmaceuticals, Inc. (-1.74), greater than VectivBio Holding AG (-7.94),

Build a custom stock screener for Rigel Pharmaceuticals, Inc. (RIGL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Rigel Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Rigel Pharmaceuticals, Inc. (RIGL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Rigel Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.